Helen Simkins

Helen Simkins, PhD has a diverse work experience in the field of scientific research and medical writing. Their most recent position is as a Senior Scientific Director at Envision Pharma Group, where they currently work. Prior to this, they held roles at PRECISIONscientia, formerly known as ETHOS Health Communications, where they were a Scientific Director and an Associate Scientific Director. At PRECISIONscientia, Helen was responsible for interpreting and communicating innovative medical science. Helen also worked as a Senior Medical Writer at the same company. Before joining PRECISIONscientia, Helen had an internship at Susan G. Komen Philadelphia as an Intern to the Program Director of Grants & Public Policy.

Earlier in their career, Helen worked as a Medical Writer at Pollen Health, where they were responsible for writing and editing scientific documents. Helen also conducted literature searches and collaborated with the creative department on project design. Prior to that, Helen was a Postdoctoral Researcher at the University of Pennsylvania, where they investigated immune cell interactions and mentored students and lab technicians. Helen also worked as a PhD student at the Malaghan Institute of Medical Research, focusing on the regulation of dendritic cell survival by cytotoxic T lymphocytes and natural killer T cells.

Overall, Helen Simkins, PhD has a strong background in scientific research, medical writing, and interpreting and communicating medical science.

Helen Simkins, PhD, earned their Doctor of Philosophy (Ph.D.) degree in Cellular and Molecular Biology (Immunology) from Victoria University of Wellington, completing their studies from 2005 to 2009. Prior to that, they obtained their BSc (Hons) degree in Biochemistry from the University of Otago, graduating between 2000 and 2003. Helen began their educational journey at Otago Girls' High School, where they attended from 1995 to 1999.